Document:

<PAGE>

                                                                     EXHIBIT 4.3

                                                                  Execution Copy

                           XCEL PHARMACEUTICALS, INC.

                              (formerly MJBC Corp.)

                           INVESTORS' RIGHTS AGREEMENT

                                 March 30, 2001

<PAGE>

                                TABLE OF CONTENTS

<TABLE>
<CAPTION>
                                                                                            Page
                                                                                            ----
<S>                                                                                         <C>
1.  Registration Rights ................................................................       1

    1.1    Definitions .................................................................       1
    1.2    Request for Registration ....................................................       2
    1.3    Company Registration ........................................................       4
    1.4    Obligations of the Company ..................................................       4
    1.5    Furnish Information .........................................................       5
    1.6    Expenses of Registration ....................................................       5
    1.7    Form S-3 Registration .......................................................       6
    1.8    Underwriting Requirements ...................................................       6
    1.9    Delay of Registration .......................................................       7
    1.10   Indemnification .............................................................       7
    1.11   Reports Under Securities Exchange Act of 1934 ...............................       9
    1.12   Assignment of Registration Rights ...........................................      10
    1.13   Limitations on Subsequent Registration Rights ...............................      10
    1.14   "Market Stand-Off" Agreement ................................................      10
    1.15   Termination of Registration Rights. .........................................      11

2.  Covenants of the Company ...........................................................      11

    2.1    Delivery of Financial Statements. ...........................................      11
    2.2    Inspection ..................................................................      12
    2.3    Termination of Information and Inspection Covenants .........................      12

3.  Miscellaneous ......................................................................      12

    3.1    Permitted Assigns ...........................................................      12
    3.2    Successors and Assigns ......................................................      13
    3.3    Governing Law ...............................................................      13
    3.4    Counterparts ................................................................      13
    3.5    Titles and Subtitles ........................................................      13
    3.6    Notices .....................................................................      13
    3.7    Expenses ....................................................................      13
    3.8    Amendments and Waivers ......................................................      13
    3.9    Severability ................................................................      14
    3.10   Aggregation of Stock ........................................................      14
    3.11   Entire Agreement; Amendment; Waiver .........................................      14
</TABLE>

Schedule A        Schedule of Investors
----------

                                      -i-

<PAGE>

                           INVESTORS' RIGHTS AGREEMENT

         This Investors' Rights Agreement (this "Agreement") is made on the 30th
day of March, 2001, by and among Xcel Pharmaceuticals, Inc. (formerly MJBC
Corp.), a Delaware corporation (the "Company") and the investors listed on
Schedule A hereto, each of which is herein referred to as an "Investor." In
----------
addition, other persons and entities purchasing Series A-1 Preferred Stock (as
defined below) from the Company pursuant to the Series A-1 Agreement (as defined
below) may elect to join this Agreement by tendering an executed signature page
to the Company. Upon tendering such signature page to the Company, such person
or entity shall be deemed an Investor hereunder.

                                    RECITALS
                                    --------

         A.   The Company and the Investors are parties to the Series A-1
Preferred Stock Purchase Agreement of even date herewith (the "Series A-1
Agreement") pursuant to which the Investors are purchasing shares of the
Company's Series A-1 Preferred Stock (together with the Company's Series A-2
Preferred Stock, Series A-3 Preferred Stock and Series A-4 Preferred Stock, the
"Series A Preferred Stock"); and

         B.   In order to induce the Company to enter into the Series A-1
Agreement and to induce the Investors to invest funds in the Company pursuant to
the Series A-1 Agreement, the Investors and the Company hereby agree that this
Agreement shall govern the rights of the Investors to cause the Company to
register shares of its Common Stock ("Common Stock") issuable to the Investors
and certain other matters as set forth herein.

         NOW, THEREFORE, THE PARTIES HEREBY AGREE AS FOLLOWS:

                                    AGREEMENT
                                    ---------

         1.   Registration Rights. The Company covenants and agrees as follows:
              -------------------

              1.1    Definitions. For purposes of this Section 1:
                     -----------                       ---------

                     (a)    The term "Act" means the Securities Act of 1933, as
amended.

                     (b)    The term "Form S-3" means such form under the Act as
in effect on the date hereof or any registration form under the Act subsequently
adopted by the SEC which permits inclusion or incorporation of substantial
information by reference to other documents filed by the Company with the SEC.

                     (c)    The term "Holder" means any person owning or having
the right to acquire Registrable Securities or any assignee thereof in
accordance with Section 1.13 below.
                ------------

                     (d)    The term "1934 Act" shall mean the Securities
Exchange Act of 1934, as amended.

<PAGE>

              (e)    The terms "register," "registered," and "registration"
refer to a registration effected by preparing and filing a registration
statement or similar document in compliance with the Act, and the declaration or
ordering of effectiveness of such registration statement or document.

              (f)    The term "Registrable Securities" means (i) the Common
Stock issuable or issued upon conversion of the Series A Preferred Stock, and
(ii) any Common Stock issued as (or issuable upon the conversion or exercise of
any warrant, right or other security which is issued as) a dividend or other
distribution with respect to, or in exchange for or in replacement of the shares
referenced in (i) above, excluding in all cases, however, any Registrable
Securities (x) sold by a person in a transaction in which his or her rights
under this Section 1 are not assigned, (y) which have previously been registered
           ---------
or (z) which have been sold pursuant to Rule 144 under the Act.

              (g)    The number of shares of "Registrable Securities then
outstanding" shall be determined by the number of shares of Common Stock
outstanding which are, and the number of shares of Common Stock issuable
pursuant to then exercisable or convertible securities which are, Registrable
Securities.

              (h)    The term "SEC" shall mean the Securities and Exchange
Commission.

         1.2  Request for Registration.
              ------------------------

              (a)    If the Company shall receive at any time after the earlier
of (i) March 30, 2006, or (ii) six (6) months after the effective date of the
       --------------          --- ---
first registration statement for a public offering of securities of the Company
(other than a registration statement relating either to the sale of securities
to employees of the Company pursuant to a stock option, stock purchase or
similar plan or a SEC Rule 145 transaction), a written request from the Holders
of not less than thirty percent (30%) the Registrable Securities then
                 --------------  ---
outstanding that the Company file a registration statement under the Act
covering the registration of the greater of (x) thirty percent (30%) of the
                                                --------------  ---
Registrable Securities then outstanding, and (y) a number of Registrable
Securities with an anticipated aggregate offering price, net of underwriting
discounts and commissions, of at least Ten Million Dollars ($10,000,000), then
                                       -------------------  -----------
the Company shall:

                     (i)   within ten (10) days of the receipt thereof, give
                                  ---  --
written notice of such request to all Holders; and

                     (ii)  effect as soon as practicable, and in any event file
within sixty (60) days (ninety (90) days for an initial registered public
       -----  --        ------  --
offering of Common Stock) of the receipt of such request (which request must be
made within twenty (20) days of the mailing by the Company of the notice
            ------  --
described in Section 1.2(a)(i) above in accordance with Section 3.6 below), the
             -----------------                          -----------
registration under the Act of all Registrable Securities which the Holders
request to be registered, subject to the limitations of Section 1.2(b) below.
                                                        --------------

              (b)    If the Holders initiating the registration request
hereunder (the "Initiating Holders") intend to distribute the Registrable
Securities covered by their request by means of an underwriting, they shall so
advise the Company as a part of their request made

                                      -2-

<PAGE>

pursuant to Section 1.2(a) above and the Company shall include such information
            --------------
in the written notice referred to in Section 1.2(a) above. The underwriter will
                                     --------------
be selected by a majority of the Initiating Holders and shall be reasonably
acceptable to the Company. In such event, the right of any Holder to include its
Registrable Securities in such registration shall be conditioned upon such
Holder's participation in such underwriting and the inclusion of such Holder's
Registrable Securities in the underwriting (unless otherwise mutually agreed by
a majority in interest of the Initiating Holders and such Holder) to the extent
provided herein. All Holders proposing to distribute their securities through
such underwriting shall (together with the Company as provided in Section 1.4(e)
                                                                  --------------
below) enter into an underwriting agreement in customary form with the
underwriter or underwriters selected for such underwriting. Notwithstanding any
other provision of this Section 1.2, if the underwriter advises the Initiating
                        -----------
Holders in writing that marketing factors require a limitation of the number of
shares to be underwritten, then the Initiating Holders shall so advise all
Holders of Registrable Securities which would otherwise be underwritten pursuant
hereto, and the number of shares of Registrable Securities that may be included
in the underwriting shall be allocated among all Holders thereof, including the
Initiating Holders, in proportion (as nearly as practicable) to the amount of
Registrable Securities of the Company owned by each Holder; provided, however,
                                                            --------  -------
that the number of shares of Registrable Securities to be included in such
underwriting shall not be reduced unless all other securities are first entirely
excluded from the underwriting.

              (c)    Notwithstanding the foregoing, if the Company shall furnish
to Holders requesting a registration statement pursuant to this Section 1.2, a
                                                                -----------
certificate signed by the Company's Chief Executive Officer stating that in the
good faith judgment of the Company's Board of Directors (the "Board"), it would
be seriously detrimental to the Company and its stockholders for such
registration statement to be filed and it is therefore essential to defer the
filing of such registration statement, the Company shall have the right to defer
taking action with respect to such filing for a period of not more than One
                                                                        ---
Hundred Twenty (120) days after receipt of the request of the Initiating
--------------  ---
Holders; provided, however, that the Company may not utilize this right more
         --------  -------
than once in any twelve (12)-month period.
                 ------  --

              (d)    In addition, the Company shall not be obligated to effect,
or to take any action to effect, any registration pursuant to this Section 1.2:
                                                                   -----------

                     (i)    After the Company has effected two (2) registrations
                                                           --- ---
pursuant to this Section 1.2 and such registrations have been declared or
                 -----------
ordered effective;

                     (ii)   During the period starting with the date thirty (30)
                                                                     ------  --
days prior to the Company's good faith estimate of the date of filing of, and
ending on a date one hundred eighty (180) days after the effective date of, a
                 ------------------  ---
registration subject to Section 1.3 below; provided that the Company is actively
                        -----------
employing in good faith all reasonable efforts to cause such registration
statement to become effective; or

                     (iii)  If the Initiating Holders propose to dispose of
shares of Registrable Securities that may be registered on Form S-3 pursuant to
a request made pursuant to Section 1.7 below.
                           -----------

                                       -3-

<PAGE>

             1.3   Company Registration. If the Company proposes to register
                   --------------------
(including for this purpose a registration effected by the Company for
stockholders other than the Holders) any of its stock or other securities under
the Act in connection with the public offering of such securities solely for
cash (other than a registration pursuant to (a) a firmly underwritten initial
public offering of shares of Common Stock at a per share price of not less than
Ten Dollars ($10.00) (subject to appropriate adjustment for stock splits, stock
-----------   ------
dividends, combinations and other recapitalizations) and an aggregate offering
price of not less than Sixty Million Dollars ($60,000,000) (a "Qualifying IPO")
                       ---------------------   ----------
or (b) Form S-8 or Form S-4, or similar forms which may be promulgated in the
future), the Company shall, at such time, promptly give each Holder written
notice of such registration. Upon the written request of each Holder given
within twenty (20) days after mailing of such notice by the Company in
       ------  --
accordance with Section 3.5 below, the Company shall, subject to the provisions
                -----------
of Section 1.8 below, cause to be registered under the Act all of the
   -----------
Registrable Securities that each such Holder has requested to be registered.

             1.4   Obligations of the Company. Whenever required under this
                   --------------------------
Section 1 to effect the registration of any Registrable Securities, the Company
---------
shall, as expeditiously as reasonably possible:

                   (a)    Prepare and file with the SEC a registration statement
with respect to such Registrable Securities and use its best efforts to cause
such registration statement to become effective, and, upon the request of the
Holders of a majority of the Registrable Securities registered thereunder, keep
such registration statement effective for a period of up to 120 days; provided,
                                                            ---       --------
however, that (i) such 120-day period shall be extended for a period of time
-------                ---
equal to the period the Holder refrains from selling any securities included in
such registration at the request of an underwriter of Common Stock (or other
securities) of the Company; and (ii) in the case of any registration of
Registrable Securities on Form S-3 which are intended to be offered on a
continuous or delayed basis, such 120-day period shall be extended, if
                                  ---
necessary, to keep the registration statement effective until all such
Registrable Securities are sold, provided, however, that Rule 415, or any
                                 --------  -------
successor rule under the Act, permits an offering on a continuous or delayed
basis, and provided, further, that applicable rules under the Act governing the\
           --------  -------
obligation to file a post-effective amendment permit, in lieu of filing a
post-effective amendment which (I) includes any prospectus required by Section
10(a)(3) of the Act or (II) reflects facts or events representing a material or
fundamental change in the information set forth in the registration statement,
the incorporation by reference of information required to be included in (I) and
(II) above to be contained in periodic reports filed pursuant to Section 13 or
15(d) of the 1934 Act in the registration statement.

                   (b)    Prepare and file with the SEC such amendments and
supplements to such registration statement and the prospectus used in connection
with such registration statement as may be necessary to comply with the
provisions of the Act with respect to the disposition of all securities covered
by such registration statement.

                   (c)    Furnish to the Holders such numbers of copies of a
prospectus, including a preliminary prospectus, in conformity with the
requirements of the Act, and such other documents as they may reasonably request
in order to facilitate the disposition of Registrable Securities owned by them.

                                       -4-

<PAGE>

                    (d)    Use its best efforts to register and qualify the
securities covered by such registration statement under such other securities or
Blue Sky laws of such jurisdictions as shall be reasonably requested by the
Holders; provided, however, that the Company shall not be required in connection
         --------  -------
therewith or as a condition thereto to qualify to do business or to file a
general consent to service of process in any such states or jurisdictions,
unless the Company is already subject to service in such jurisdiction and except
as may be required by the Act.

                  (e)      In the event of any underwritten public offering,
enter into and perform its obligations under an underwriting agreement, in usual
and customary form, with the managing underwriter of such offering.

                  (f)      Notify each Holder of Registrable Securities covered
by such registration statement at any time when a prospectus relating thereto is
required to be delivered under the Act of the happening of any event as a result
of which the prospectus included in such registration statement, as then in
effect, includes an untrue statement of a material fact or omits to state a
material fact required to be stated therein or necessary to make the statements
therein not misleading in the light of the circumstances then existing.

                  (g)      Cause all such Registrable Securities registered
pursuant hereunder to be listed on each securities exchange on which similar
securities issued by the Company are then listed.

                  (h)      Provide a transfer agent and registrar for all
Registrable Securities registered pursuant hereunder and a CUSIP number for all
such Registrable Securities, in each case not later than the effective date of
such registration.

              1.5   Furnish Information. It shall be a condition precedent to
                    -------------------
the obligations of the Company to take any action pursuant to this Section 1
                                                                   ---------
with respect to the Registrable Securities of any selling Holder that such
Holder shall furnish to the Company such information regarding itself, the
Registrable Securities held by it, and the intended method of disposition of
such securities as shall be required to effect the registration of such Holder's
Registrable Securities.

              1.6   Expenses of Registration. All expenses other than
                    ------------------------
underwriting discounts and commissions incurred in connection with
registrations, filings or qualifications pursuant to Sections 1.2 and 1.3 above
                                                     -------- ---     ---
and Section 1.7 below, including (without limitation) all registration, filing
    ------- ---
and qualification fees, printers' and accounting fees, fees and disbursements of
counsel for the Company and the fees and disbursements (not to exceed Fifteen
                                                                      -------
Thousand Dollars ($15,000) for each registration) of one (1) counsel for the
----------------   ------                            ---  -
selling Holders shall be borne by the Company; provided, however, that the
                                               --------  -------
Company shall not be required to pay for any expenses of any registration
proceeding begun pursuant to Section 1.2 above or Section 1.7 below if the
                             -----------          -----------
registration request is subsequently withdrawn at the request of the Holders of
a majority of the Registrable Securities to be registered (in which case all
participating holders shall bear such expenses), unless the Holders of a
majority of the Registrable Securities agree to forfeit their right to one
demand registration pursuant to Section 1.2 above or one registration on Form
                                -----------
S-3 pursuant to Section 1.7 below, as applicable; provided, further, however,
                -----------                       --------  -------  -------
that if at the time of such withdrawal, the Holders have learned of a material
adverse change in the condition,

                                       -5-

<PAGE>

business, or prospects of the Company from that known to the Holders at the time
of their request and have withdrawn the request with reasonable promptness
following disclosure by the Company of such material adverse change, then the
Holders shall not be required to pay any of such expenses and shall retain their
rights pursuant to Section 1.2 above or one registration on Form S-3 pursuant to
                   -----------
Section 1.7 below, as applicable.
-----------

              1.7    Form S-3 Registration. In the event that the Company shall
                     ---------------------
receive from any Holder or Holders of the Registrable Securities then
outstanding a written request or requests that the Company effect a registration
on Form S-3 and any related qualification or compliance with respect to all or a
part of the Registrable Securities owned by such Holder or Holders, the Company
will:

                     (a)   promptly give written notice of the proposed
registration, and any related qualification or compliance, to all other Holders;
and

                     (b)   as soon as practicable, effect such registration and
all such qualifications and compliances as may be so requested and as would
permit or facilitate the sale and distribution of all or such portion of such
Holder's or Holders' Registrable Securities as are specified in such request,
together with all or such portion of the Registrable Securities of any other
Holder or Holders joining in such request as are specified in a written request
given within fifteen (15) days after receipt of such written notice from the
             -------  --
Company; provided, however, that the Company shall not be obligated to effect
         --------  -------
any such registration, qualification or compliance, pursuant to this Section
                                                                     -------
1.7: (1) if Form S-3 is not available for such offering by the Holders; (2) if
---
the Holders, together with the holders of any other securities of the Company
entitled to inclusion in such registration, propose to sell Registrable
Securities and such other securities (if any) at an aggregate price to the
public (net of any underwriters' discounts or commissions) of less than Two
                                                                        ---
Million Five Hundred Thousand Dollars ($2,500,000); (3) if the Company shall
-------------------------------------   ---------
furnish to the Holders a certificate signed by the Company's Chief Executive
Officer stating that in the good faith judgment of the Board, it would be
seriously detrimental to the Company and its stockholders for such Form S-3
Registration to be effected at such time, in which event the Company shall have
the right to defer the filing of the Form S-3 registration statement for a
period of not more than one hundred twenty (120) days after receipt of the
                        ------------------  ---
request of the Holder or Holders under this Section 1.7; provided, however, that
                                            -----------  --------  -------
the Company shall not utilize this right more than once in any twelve (12) month
                                                                       --
period; or (4) if the Company has, within the twelve (12)-month period preceding
                                              ------  --
the date of such request, already effected two (2) registrations on Form S-3 for
                                           ---  -
the Holders pursuant to this Section 1.7.
                             -----------

                     (c)   Subject to the foregoing, the Company shall file a
registration statement covering the Registrable Securities and other securities
so requested to be registered as soon as practicable after receipt of the
request or requests of the Holders. Registrations effected pursuant to this
Section 1.7 shall not be counted as demands for registration or registrations
-----------
effected pursuant to Sections 1.2 or 1.3 above, respectively.
                     ------------    ---

              1.8    Underwriting Requirements. In connection with any offering
                     -------------------------
involving an underwriting of shares of the Company's capital stock, the Company
shall not be required under Section 1.3 above to include any of the Holders'
                            -----------
securities in such underwriting unless they accept the terms of the underwriting
as agreed upon between the Company and the underwriters

                                       -6-

<PAGE>

selected by it (or by other persons entitled to select the underwriters), and
then only in such quantity as the underwriters determine in their sole
discretion will not jeopardize the success of the offering by the Company. If
the total amount of securities, including Registrable Securities, requested by
stockholders to be included in such offering exceeds the amount of securities
sold other than by the Company that the underwriters determine in their sole
discretion is compatible with the success of the offering, then the Company
shall be required to include in the offering only that number of such
securities, including Registrable Securities, which the underwriters determine
in their sole discretion will not jeopardize the success of the offering (the
securities so included to be apportioned pro rata among the selling stockholders
according to the total amount of securities entitled to be included therein
owned by each selling stockholder or in such other proportions as shall mutually
be agreed to by such selling stockholders) but in no event shall the amount of
securities of the selling Holders included in the offering be reduced below
twenty-five percent (25%) of the total amount of securities included in such
------------------- -----
offering, unless such offering is the initial public offering of the Company's
securities in which case the selling stockholders may be excluded entirely if
the underwriters make the determination described above and no other
stockholder's securities are included. For purposes of the preceding
parenthetical concerning apportionment, for any selling stockholder which is a
holder of Registrable Securities and which is a partnership or corporation, the
partners, retired partners and stockholders of such holder, or the estates and
family members of any such partners and retired partners and any trusts for the
benefit of any of the foregoing persons shall be deemed to be a single "selling
stockholder," and any pro-rata reduction with respect to such "selling
stockholder" shall be based upon the aggregate amount of shares carrying
registration rights owned by all entities and individuals included in such
"selling stockholder," as defined in this sentence.

             1.9   Delay of Registration. No Holder shall have any right to
                   ---------------------
obtain or seek an injunction restraining or otherwise delaying any registration
as the result of any controversy that might arise with respect to the
interpretation or implementation of this Section 1.
                                         ---------

             1.10  Indemnification. In the event any Registrable Securities are
                   ---------------
included in a registration statement under this Section 1:
                                                ---------

                   (a)     To the extent permitted by law, the Company will
indemnify and hold harmless each Holder and such Holders' respective officers,
directors, affiliates, employees and representatives, any underwriter (as
defined in the Act) for such Holder and each person, if any, who controls such
Holder or underwriter within the meaning of the Act or the 1934 Act, against any
losses, claims, damages, or liabilities (joint or several) to which they may
become subject under the Act or the 1934 Act insofar as such losses, claims,
damages, or liabilities (or actions in respect thereof) arise out of or are
based upon any of the following statements, omissions or violations
(collectively a "Violation"): (i) any untrue statement or alleged untrue
statement of a material fact contained in such registration statement, including
any preliminary prospectus or final prospectus contained therein or any
amendments or supplements thereto, (ii) the omission or alleged omission to
state therein a material fact required to be stated therein, or necessary to
make the statements therein not misleading, or (iii) any violation or alleged
violation by the Company of the Act, the 1934 Act, any state securities law or
any rule or regulation promulgated under the Act, the 1934 Act or any state
securities law; and the Company will reimburse each such Holder, underwriter or
controlling person any legal or other expenses reasonably incurred by them in
connection with investigating or defending any such loss, claim,

                                      -7-

<PAGE>

damage, liability, or action; provided, however, that the indemnity agreement
                              --------  -------
contained in this Section 1.10(a) shall not apply to amounts paid in settlement
                  ---------------
of any such loss, claim, damage, liability, or action if such settlement is
effected without the consent of the Company (which consent shall not be
unreasonably withheld), nor shall the Company be liable in any such case for any
such loss, claim, damage, liability, or action to the extent that it arises out
of or is based upon a Violation which occurs in reliance upon and in conformity
with written information furnished expressly for use in connection with such
registration by any such Holder, underwriter or controlling person.

               (b)  To the extent permitted by law, each selling Holder will
indemnify and hold harmless the Company, each of its directors, each of its
officers who has signed the registration statement, each person, if any, who
controls the Company within the meaning of the Act, any underwriter, any other
Holder selling securities in such registration statement and any controlling
person of any such underwriter or other Holder, against any losses, claims,
damages, or liabilities (joint or several) to which any of the foregoing persons
may become subject, under the Act, the 1934 Act or other federal or state law,
insofar as such losses, claims, damages, or liabilities (or actions in respect
thereto) arise out of or are based upon any Violation, in each case to the
extent (and only to the extent) that such Violation occurs in reliance upon and
in conformity with written information furnished by such Holder expressly for
use in connection with such registration; and each such Holder will reimburse
any legal or other expenses reasonably incurred by any person intended to be
indemnified pursuant to this Section 1.10(b), in connection with investigating
                             ---------------
or defending any such loss, claim, damage, liability, or action; provided,
                                                                 --------
however, that the indemnity agreement contained in this Section 1.10(b) shall
-------                                                 ---------------
not apply to amounts paid in settlement of any such loss, claim, damage,
liability or action if such settlement is effected without the consent of the
Holder, which consent shall not be unreasonably withheld; provided, that, in no
                                                          --------
event shall any indemnity under this Section 1.10(b) exceed the gross proceeds
                                     ---------------
from the offering received by such Holder.

               (c)  Promptly after receipt by an indemnified party under this
Section 1.10 of notice of the commencement of any action (including any
------------
governmental action), such indemnified party will, if a claim in respect thereof
is to be made against any indemnifying party under this Section 1.10, deliver to
                                                        ------------
the indemnifying party a written notice of the commencement thereof and the
indemnifying party shall have the right to participate in, and, to the extent
the indemnifying party so desires, jointly with any other indemnifying party
similarly noticed, to assume the defense thereof with counsel mutually
satisfactory to the parties; provided, however, that an indemnified party
                             --------  -------
(together with all other indemnified parties which may be represented without
conflict by one counsel) shall have the right to retain one separate counsel,
with the fees and expenses to be paid by the indemnifying party, if
representation of such indemnified party by the counsel retained by the
indemnifying party would be inappropriate due to actual or potential differing
interests between such indemnified party and any other party represented by such
counsel in such proceeding. The failure to deliver written notice to the
indemnifying party within a reasonable time of the commencement of any such
action, if prejudicial to its ability to defend such action, shall relieve such
indemnifying party of any liability to the indemnified party under this Section
                                                                        -------
1.10, but the omission so to deliver written notice to the indemnifying party
----
will not relieve it of any liability that it may have to any indemnified party
otherwise than under this Section 1.10.
                          ------------

                                      -8-

<PAGE>

                (d)  If the indemnification provided for in this Section 1.10 is
                                                                 ------------
held by a court of competent jurisdiction to be unavailable to an indemnified
party with respect to any loss, liability, claim, damage, or expense referred to
therein, then the indemnifying party, in lieu of indemnifying such indemnified
party hereunder, shall contribute to the amount paid or payable by such
indemnified party as a result of such loss, liability, claim, damage, or expense
in such proportion as is appropriate to reflect the relative fault of the
indemnifying party on the one hand and of the indemnified party on the other in
connection with the statements or omissions that resulted in such loss,
liability, claim, damage, or expense as well as any other relevant equitable
considerations. The relative fault of the indemnifying party and of the
indemnified party shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the
omission to state a material fact relates to information supplied by the
indemnifying party or by the indemnified party and the parties' relative intent,
knowledge, access to information, and opportunity to correct or prevent such
statement or omission.

                (e)  Notwithstanding the foregoing, to the extent that the
provisions on indemnification and contribution contained in the underwriting
agreement entered into in connection with the underwritten public offering are
in conflict with the foregoing provisions, the provisions in the underwriting
agreement shall control.

                (f)  The obligations of the Company and Holders under this
Section 1.10 shall survive the completion of any offering of Registrable
------------
Securities in a registration statement under this Section 1, and otherwise.
                                                  ---------

          1.11  Reports Under Securities Exchange Act of 1934. With a view to
                ---------------------------------------------
making available to the Holders the benefits of Rule 144 promulgated under the
Act and any other rule or regulation of the SEC that may at any time permit a
Holder to sell securities of the Company to the public without registration or
pursuant to a registration on Form S-3, the Company agrees to:

                (a)  make and keep public information available, as those terms
are understood and defined in SEC Rule 144, at all times after ninety (90) days
                                                               ------  --
after the effective date of the first registration statement filed by the
Company for the offering of its securities to the general public;

                (b)  file with the SEC in a timely manner all reports and other
documents required of the Company under the Act and the 1934 Act; and

                (c)  furnish to any Holder, so long as the Holder owns any
Registrable Securities, forthwith upon request (i) a written statement by the
Company that it has complied with the reporting requirements of SEC Rule 144 (at
any time after ninety (90) days after the effective date of the first
               ------  --
registration statement filed by the Company), the Act and the 1934 Act (at any
time after it has become subject to such reporting requirements), or that it
qualifies as a registrant whose securities may be resold pursuant to Form S-3
(at any time after it so qualifies), (ii) a copy of the most recent annual or
quarterly report of the Company and such other reports and documents so filed by
the Company, and (iii) such other information as may be reasonably requested in
availing any Holder of any rule or regulation of the SEC which permits the
selling of any such securities without registration or pursuant to such form.

                                      -9-

<PAGE>

          1.12  Assignment of Registration Rights. The rights to cause the
                ---------------------------------
Company to register Registrable Securities pursuant to this Section 1 may be
                                                            ---------
assigned (but only with all related obligations) by a Holder to a transferee or
assignee of such securities who, after such assignment or transfer, holds at
least Two Hundred Fifty Thousand (250,000) shares of Registrable Securities
      --------------------------  -------
(subject to appropriate adjustment for stock splits, stock dividends,
combinations and other recapitalizations), provided: (a) the Company is, within
                                           --------
a reasonable time after such transfer, furnished with written notice of the name
and address of such transferee or assignee and the securities with respect to
which such registration rights are being assigned; (b) such transferee or
assignee agrees in writing to be bound by and subject to the terms and
conditions of this Agreement, including without limitation the provisions of
Section 1.14 below; and (c) such assignment shall be effective only if
------------
immediately following such transfer the further disposition of such securities
by the transferee or assignee is restricted under the Act. For the purposes of
determining the number of shares of Registrable Securities held by a transferee
or assignee, the holdings of transferees and assignees of a partnership who are
partners or retired partners of such partnership (including spouses and
ancestors, lineal descendants and siblings of such partners or spouses who
acquire Registrable Securities by gift, will or intestate succession) shall be
aggregated together and with the partnership; provided that all assignees and
                                              --------
transferees who would not qualify individually for assignment of registration
rights shall have a single attorney-in-fact for the purpose of exercising any
rights, receiving notices or taking any action under this Section 1.
                                                          ---------

          1.13  Limitations on Subsequent Registration Rights. From and after
                ---------------------------------------------
the date of this Agreement, the Company shall not, without the prior written
consent of the Holders of a majority of the outstanding Registrable Securities,
enter into any agreement with any holder or prospective holder of any securities
of the Company giving such holder or prospective holder any registration rights,
unless the terms of such agreement provide that such registration rights are
subordinate to the registration rights granted to the Holders hereunder.

          1.14  "Market Stand-Off" Agreement. Each Investor hereby agrees that,
                 ---------------------------
during the period of duration specified by the Company and an underwriter of
Common Stock or other securities of the Company, following the date of the first
sale to the public pursuant to a registration statement of the Company filed
under the Act, it shall not, to the extent requested by the Company and such
underwriter, directly or indirectly sell, offer to sell, contract to sell
(including, without limitation, any short sale), grant any option to purchase or
otherwise transfer or dispose of (other than to donees who agree to be similarly
bound) any securities of the Company held by it at any time during such period
except Common Stock included in such registration; provided, however, that:
                                                   --------  -------

                (a)  (i) all officers and directors of the Company and all other
persons with registration rights (whether or not pursuant to this Agreement)
enter into similar agreements and (ii) the Company shall use commercially
reasonable efforts to obtain similar agreements from all holders of one percent
(1%) or more of its capital stock; and

                (b)  such market stand-off time period shall not exceed (i) one
                                                                            ---
hundred eighty (180) days with respect to the first registration statement of
--------------  ---
the Company which covers Common Stock (or other securities) to be sold on its
behalf to the public in an underwritten offering and (ii) ninety (90) days for
                                                          ------  --
subsequent registration statements.

                                      -10-

<PAGE>

         In order to enforce the foregoing covenant, the Company may impose
stop-transfer instructions with respect to the Registrable Securities of each
Investor (and the shares or securities of every other person subject to the
foregoing restriction) until the end of such period.

         Notwithstanding the foregoing, the obligations described in this
Section 1.14 shall not apply to a registration relating solely to employee
------------
benefit plans on Form S-l or Form S-8 or similar forms which may be promulgated
in the future, or a registration relating solely to a Commission Rule 145
transaction on Form S-4 or similar forms which may be promulgated in the future.

          1.15 Termination of Registration Rights.
               ----------------------------------

               (a)  No Holder shall be entitled to exercise any right provided
for in this Section 1 after five (5) years following the consummation of a
            ---------       ----  -
Qualifying IPO.

               (b)  In addition, the right of any Holder to request registration
or inclusion in any registration pursuant to this Section 1 shall terminate on
                                                  ---------
the closing of the first Company-initiated registered public offering of Common
Stock if all shares of Registrable Securities held or entitled to be held upon
conversion by such Holder may immediately be sold under Rule 144 during any
ninety (90)-day period, or on such date after the closing of the first
------  --
Company-initiated registered public offering of Common Stock as all shares of
Registrable Securities held or entitled to be held upon conversion by such
Holder may immediately be sold under Rule 144 during any ninety (90)-day period.
                                                         ------  --

     2.   Covenants of the Company.
          ------------------------

          2.1  Delivery of Financial Statements. The Company shall deliver to
               --------------------------------
each Investor that holds at least Five Hundred Thousand (500,000) shares of
                                  ---------------------  -------
Registrable Securities (subject to appropriate adjustment for stock splits,
stock dividends, combination and other recapitalizations) (each such Investor, a
"Qualified Investor"):

               (a)  as soon as practicable, but in any event within ninety (90)
                                                                    ------  --
days after the end of each fiscal year of the Company, an income statement for
such fiscal year, a balance sheet of the Company and statement of stockholder's
equity as of the end of such year, and a schedule as to the sources and
applications of funds for such year, such year-end financial reports to be in
reasonable detail, prepared in accordance with generally accepted accounting
principles ("GAAP"), and audited and certified by independent public accountants
of nationally recognized standing selected by the Company;

               (b)  until March 30, 2002 (the "First Anniversary"), within
thirty (30) days of the end of each calendar month, an unaudited income
------  --
statement and schedule as to the sources and application of funds and balance
sheet for and as of the end of such month, in reasonable detail;

               (c)  following the First Anniversary, as soon as practicable, but
in any event within forty-five (45) days after the end of each of the first
                    ----------  --
three (3) quarters of each fiscal year of the Company, an unaudited profit or
-----  -
loss statement, schedule as to the sources and application of funds for such
fiscal quarter, an unaudited balance sheet and a statement of

                                      -11-

<PAGE>

stockholder's equity as of the end of such fiscal quarter and a statement
showing the number of shares of each class and series of capital stock and
securities convertible into or exercisable for shares of capital stock
outstanding at the end of the period, the number of common shares issuable upon
conversion or exercise of any outstanding securities convertible or exercisable
for common shares and the exchange ratio or exercise price applicable thereto,
all in sufficient detail as to permit the Qualified Investor to calculate its
percentage equity ownership in the Company;

               (d)  as soon as practicable, but in any event forty-five (45)
                                                             ----------  --
days prior to the end of each fiscal year, a budget of sales and expenses and
operating plan for the next fiscal year, prepared on a monthly basis, including
balance sheets and sources and applications of funds statements for such months
which such budget and operating plan shall be approved by the Board prior to the
end of each fiscal year, and, as soon as prepared, any other budgets or revised
budgets prepared by the Company;

               (e)  with respect to the financial statements called for in
subsections (b) and (c) of this Section 2.1, an instrument executed by the
                                -----------
Corporation's President or Chief Financial Officer certifying that such
financials were prepared in accordance with GAAP (provided that a certification
as to good accounting principles consistently applied shall suffice until after
the Company's financial statements are initially audited) consistently applied
with prior practice for earlier periods (with the exception of footnotes that
may be required by GAAP) and fairly present the financial condition of the
Company and its results of operation for the period specified, subject to
year-end audit adjustment; and

               (f)  such other information relating to the financial condition,
business, prospects or corporate affairs of the Company as the Qualified
Investor may from time to time request, provided, however, that the Company
                                        --------  -------
shall not be obligated under this subsection (f) or any other subsection of
Section 2.1 to provide information which it deems in good faith to be a trade
-----------
secret or similar confidential information.

          2.2  Inspection. The Company shall permit each Qualified Investor, at
               ----------
such Qualified Investor's expense, to visit and inspect the Company's
properties, to examine its books of account and records and to discuss the
Company's affairs, finances and accounts with its officers, all at such
reasonable times as may be requested by the Qualified Investor; provided,
                                                                --------
however, that the Company shall not be obligated pursuant to this Section 2.2 to
-------                                                           -----------
provide access to any information which it reasonably considers to be a trade
secret or similar confidential information.

          2.3  Termination of Information and Inspection Covenants. The
               ---------------------------------------------------
covenants set forth in Sections 2.1 and 2.2 shall terminate as to all Qualified
                       ------------     ---
Investors and be of no further force or effect upon (a) a Qualifying IPO and (b)
when there are no outstanding Registrable Securities held by Qualified
Investors, whichever event shall first occur.

     3.   Miscellaneous.
          -------------

          3.1  Permitted Assigns. Except as otherwise expressly provided in
               -----------------
Section 1.13 above, the rights and obligations of an Investor hereunder may be
------------
assigned only to (a) an Affiliate (as defined in Rule 405 promulgated under the
Act), limited partner or general

                                      -12-

<PAGE>

partner of an Investor, or another Investor, but in each instance only when such
Investor's shares of Series A Preferred Stock are then being transferred to such
assignee, or (b) such other person or entity to whom or which such Investor's
shares of Series A Preferred Stock are then being transferred, but subject in
the instance of this clause (b) to the prior written consent of the Company
(which consent may not be unreasonably withheld).

          3.2  Successors and Assigns. Except as expressly provided herein, the
               ----------------------
rights and obligations of the parties hereto may not be assigned. Without
limiting the foregoing, the terms and conditions of this Agreement shall inure
to the benefit of and be binding upon the respective successors and, where
applicable, permitted assigns of the parties. Nothing in this Agreement, express
or implied, is intended to confer upon any party other than the parties hereto
or their respective successors and, where applicable, permitted assigns any
rights, remedies, obligations, or liabilities under or by reason of this
Agreement, except as expressly provided in this Agreement.

          3.3  Governing Law. This Agreement shall be governed by and construed
               -------------
under the laws of the State of California as applied to agreements among
California residents entered into and to be performed entirely within
California.

          3.4  Counterparts. This Agreement may be executed in two (2) or more
               ------------                                    ---  -
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.

          3.5  Titles and Subtitles. The titles and subtitles used in this
               --------------------
Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement.

          3.6  Notices. Unless otherwise provided, any notice required or
               -------
permitted under this Agreement shall be given in writing and shall be deemed
effectively given upon (a) personal delivery to the party to be notified, (b)
two (2) days following facsimile transmission to the party to be notified or (c)
---  -
five (5) days following deposit with the United States Post Office, by
----  -
registered or certified mail, postage prepaid and addressed to the party to be
notified at the address indicated for such party on the signature page hereof,
or at such other address as such party may designate by ten (10) days' advance
                                                        ---  --
written notice to the other parties.

          3.7  Expenses. If any action at law or in equity is necessary to
               --------
enforce or interpret the terms of this Agreement, the prevailing party shall be
entitled to reasonable attorneys' fees, costs and necessary disbursements in
addition to any other relief to which such party may be entitled.

          3.8  Amendments and Waivers. Any term of this Agreement may be amended
               ----------------------
and the observance of any term of this Agreement may be waived (either generally
or in a particular instance and either retroactively or prospectively), only
with the written consent of the Company and the holders of a majority of the
Registrable Securities then outstanding. Any amendment or waiver effected in
accordance with this Section shall be binding upon each holder of any
Registrable Securities then outstanding, each future holder of all such
Registrable Securities, and the Company.

                                      -13-

<PAGE>

          3.9   Severability. If one or more provisions of this Agreement are
                ------------
held to be unenforceable under applicable law, such provision shall be excluded
from this Agreement and the balance of the Agreement shall be interpreted as if
such provision were so excluded and shall be enforceable in accordance with its
terms.

          3.10  Aggregation of Stock. For purposes of this Agreement, all shares
                --------------------
of Registrable Securities held by a general partner, limited partner or
affiliated partnership of an Investor that is a limited partnership shall be
aggregated together for purposes of determining the availability of the rights
of such limited partnership Investor under this Agreement.

          3.11  Entire Agreement; Amendment; Waiver. This Agreement (including
                -----------------------------------
any schedules attached hereto) constitutes the full and entire understanding and
agreement between the parties with regard to the subjects hereof and thereof.

                            [Signature page follows]

                                      -14-

<PAGE>

     IN WITNESS WHEREOF, the parties have executed this Agreement as of the date
first above written.

                                     XCEL PHARMACEUTICALS, INC.

                                     /s/ Michael T. Borer
                                     -----------------------------------
                                     By:   Michael T. Borer

                                     Its:  Chief Executive Officer

                                     Address:   7475 Lusk Boulevard
                                                San Diego, CA 92121

                                      -15-

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                               New Enterprise Associates 10, Limited Partnership
                               By: NEA Partners 10, Limited Partnership

                               By:  /s/ [Illegible]
                                    ------------------------------------
                               Its: General Partner

                               Address     New Enterprise Associates
                                           1119 St. Paul Street
                                           Baltimore, MD 21202

Shares of Series A-1 Preferred Stock: 5,000,000
                                      ------------------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                    Elan International Services, Ltd., a Bermuda
                                    corporation

                                    By:  /s/ [Illegible]
                                         ---------------------------------------
                                    Its: Vice President

                                    Address:   102 St. James Court
                                               Flatts, Smiths, FL04, Bermuda

Shares of Series A-1 Preferred Stock: 3,000,000
                                      ------------------------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                              DP V ASSOCIATES, L.P
                                              By:  One Palmer Square
                                                   Associates V, L.L.C.
                                                   its General Partner

                                              By:  /s/ Kathleen K. Schoemaker
                                                   -----------------------------
                                                   Managing Member

                                              Address

                                              One Palmer Square, Suite 515
                                              Princeton, NJ 08542

Shares of Series A-1 Preferred Stock: 118,000
                                      ---------------------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                            DOMAIN PARTNERS V, L.P.
                                            By:   One Palmer Square
                                                  Associates V, L.L.C.,
                                                  its General Partner

                                            By:   /s/ Kathleen K. Schoemaker
                                                  ------------------------------
                                                  Managing Member

                                            Address

                                            One Palmer Square, Suite 515
                                            Princeton, NJ  08542

Shares of Series A-1 Preferred Stock: 5,000,000
                                      --------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                        NEA Ventures 2001, L.P.

                                        By:  /s/  [Illegible]
                                             -----------------------------------
                                        Its: Vice President

                                        Address

                                        New Enterprise Associates
                                        1119 St. Paul Street
                                        Baltimore, MD 20202

Shares of Series A-1 Preferred Stock: 2,600
                                      ------------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                Cam L. Garner and Wanda D. Garner, Co-Trustees
                                of the Garner Family Trust dated 10/21/87

                                By:   /s/ Cam L. Garner
                                      ------------------------------------------
                                Its:  Trustee
                                      ------------------------------------------

                                Address

                                P.O. Box 675866
                                5949 Greensview Ct,
                                Rancho Santa Fe. CA 92067

Shares of Series A-1 Preferred Stock: 60,000
                                      ------------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                Michael T. Borer

                                By:   /s/ Michael Borer
                                      -----------------------------------
                                Its:  N/A
                                      -----------------------------------

                                Address

                                806 N. Rios Ave.
                                Solona Beach, CA 92075

Shares of Series A-1 Preferred Stock: 100,000
                                      ------------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                James L. Fares

                                By:   /s/ James L. Fares
                                      ------------------------------------------
                                Its:  N/A
                                      ------------------------------------------

                                Address

                                53 Park Lane Dr.
                                Orinda, CA 94563

Shares of Series A-1 Preferred Stock: 9,000
                                      -------------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                John R. Cook

                                By:   /s/ John R. Cook
                                      ------------------------------------------
                                Its:  __________________________________________

                                Address

                                2165 Vista La Nisa
                                Carlsbad, CA 92009

Shares of Series A-1 Preferred Stock: 19,000
                                      -------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

         The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                             George Stuart

                                             By:    /s/  George Stuart
                                                    ----------------------------
                                             Its:   ____________________________

                                             Address

                                             520 Del Corro Court
                                             Chula Vista, CA 91910

Shares of Series A-1 Preferred Stock:        4,000
                                       --------------------------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

         The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                            Todd B. Sisitsky

                                            By:    /s/  Todd B. Sisitsky
                                                   -----------------------------
                                            Its:   _____________________________

                                            Address

                                            137 E. 36/th/ #200
                                            New York, NY 10016

Shares of Series A-1 Preferred Stock:  10,000
                                       --------------------------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

         The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                   Charles Ashton Newhall

                                   By:     /s/  Charles Ashton Newhall
                                           -------------------------------------
                                   Its:    _____________________________________

                                   Address

                                   4750 Owings Mills Blvd.
                                   Owings Mills, MD 21117

Shares of Series A-1 Preferred Stock:  100,000

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

         The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                              Ryan Drant

                                              By:    /s/  Ryan Drant
                                                     ---------------------------
                                              Its:   ___________________________

                                              Address

                                              1119 St. Paul Street
                                              Baltimore, MD 21202

Shares of Series A-1 Preferred Stock:  5,000
                                       --------------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

         The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                         Charles M. Linehan

                                         By:    /s/  Charles M. Linehan
                                                --------------------------------
                                         Its:   ________________________________

                                         Address

                                         4732 17/th/ Street
                                         San Francisco, CA 94117

Shares of Series A-1 Preferred Stock:  5,000
                                       ----------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                Hale Family Trust

                                By:   /s/  David F. Hale
                                      ------------------------------------------
                                Its:  Trustee
                                      ------------------------------------------

                                Address

                                P.O. Box 8925
                                16956 Via Lago Azul
                                Rancho Santa Fe, CA 92067

Shares of Series A-1 Preferred Stock: $100,000     20,000 Shares
                                      -----------------------------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                Mitchell R. Woodbury Trust Dated 7-31-95

                                By:   /s/  Mitchell R. Woodbury
                                      ------------------------------------------
                                Its:  Trustee
                                      ------------------------------------------

                                Address

                                4257 Ingleside Ave.
                                San Diego, CA 92103

Shares of Series A-1 Preferred Stock: 10,000
                                      ------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                Walter F. Spath

                                By:   /s/  Walter F. Spath
                                      ------------------------------------------
                                Its:  __________________________________________

                                Address

                                13366 Pantera Road
                                San Diego, CA 92130

Shares of Series A-1 Preferred Stock: 15,000
                                      --------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                The David M. Preston Living Trust dated 11/28/00

                                By:   /s/  Swan M. Preston
                                      ------------------------------------------
                                      /s/ David M. Preston
                                      ------------------------------------------
                                Its:  Trustees
                                      ------------------------------------------

                                Address

                                106 Majestic Ct.
                                Chapel Hill, NC 27514

Shares of Series A-1 Preferred Stock: 10,000
                                      --------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                John B. Kiernan, Jr.

                                By:   /s/ John B. Kiernan
                                      ------------------------------------------
                                Its:  __________________________________________

                                Address

                                19 Birchwood Drive
                                Greenwich, CT 06831

Shares of Series A-1 Preferred Stock: 10,000
                                      --------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                       Richard Landgarten

                                       By:   /s/ Richard Landgarten
                                             -----------------------------------
                                       Its:  Trustees
                                             -----------------------------------

                                       Address

                                       233 E. 69/th/ #96
                                       New York, NY 10021

Shares of Series A-1 Preferred Stock: 10,000
                                      --------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                       Richard R. Vietor

                                       By:  /s/ Richard R. Vietor
                                            ---------------------
                                       Its: Trustees
                                            ------------------------------------

                                       Address

                                       One East End Ave.
                                       New York, N.Y. 10021

Shares of Series A-1 Preferred Stock:  10,000
                                       --------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                       W. Robert Dahl GST Trust

                                       By:   /s/  W. R. Dahl
                                             -----------------------------------
                                       Its:  Trustee
                                             -----------------------------------

                                       Address

                                       46 Quail Rd.
                                       Greenwich, CT 06831

Shares of Series A-1 Preferred Stock: 15,000
                                      -------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                       Evergreen Ventures LLC

                                       By:   /s/  Jonathan D. Joseph
                                             -----------------------------------
                                       Its:  Managing Member
                                             -----------------------------------

                                       Address

                                       Attn: Ken Sikora Rm. 476
                                       50 Fremont St.
                                       San Francisco, CA 94105

Shares of Series A-1 Preferred Stock: 20,000
                                      ------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                  R&R Xcel LLC

                                  By:   /s/  John G. [Illegible] for R&R Capital
                                        ----------------------------------------
                                        Partners I
                                        ------------
                                  Its:  Manager
                                        -----------------------------------

                                  Address

                                  c/o R&R Capital Partners I
                                  1250 Broadway 14/th/ Fl.
                                  New York, NY 10001

Shares of Series A-1 Preferred Stock: 60,000
                                      --------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

         The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                           Thomas D. Erlandson

                                           By:      /s/  Thomas D. Erlandson
                                                    --------------------------
                                           Its:     Thomas  D. Erlandson
                                                    --------------------------

                                           Address

                                           1045 Posse Road
                                           Castle Rock, CO 80104

Shares of Series A-1 Preferred Stock:  50,000
                                       --------------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

         The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                            Jerry E. Canning

                                            By:    /s/  Jerry E. Canning
                                                   ---------------------------
                                            Its:   Myself
                                                   ---------------------------

                                            Address

                                            13561 Sunset View Road
                                            Poway, CA 92064-5050

Shares of Series A-1 Preferred Stock:  20,000
                                       --------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

         The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                   Abbott Investment Co., LLC

                                   By:      /s/  Jack Gilstrap
                                            -----------------------------------
                                   Its:     Manager
                                            -----------------------------------

                                   Address

                                   5067 Shore Drive
                                   Carlsbad, CA 92008

Shares of Series A-1 Preferred Stock: 60,000 Shares @ $5.00 a share
                                      ---------------------------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

         The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                         James C. Gilstrap IRA

                                         By:   /s/  Jack Gilstrap
                                               -------------------------------
                                         Its:  _______________________________

                                         Address

                                         5067 Shore Drive
                                         Carlsbad, CA 92008

Shares of Series A-1 Preferred Stock: 100,000 shares @ $5.00 a share
                                      ---------------------------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

         The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                         Richard Jaffe

                                         By:      /s/  Richard Jaffe
                                                  ------------------------------
                                         Its:     Managing Director
                                                  ------------------------------

                                         Address

                                         8646 Ruette Monte Carlo
                                         La Jolla, CA 92037

Shares of Series A-1 Preferred Stock:  50,000
                                       -------------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

         The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                        Ronald L. Graham

                                        By:   /s/  Ronald L. Graham
                                              -------------------------------
                                        Its:  Self
                                              -------------------------------

                                        Address

                                        9017 Shearwater Rd.
                                        Blaine, WA 98230

Shares of Series A-1 Preferred Stock:  20,000
                                       --------------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

         The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                      Alain B. Schreiber, M.D.

                                      By:   /s/  Alai B. Schreiber, M.D.
                                            ----------------------------------
                                      Its:  __________________________________

                                      Address

                                      P.O. Box 5005 - 26
                                      (Courier only:  17437 Luna De Miel)
                                      Rancho Santa Fe, CA 92067

Shares of Series A-1 Preferred Stock:  $100,000
                                       ---------------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

         The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                             Epstein Family Trust, dtd 4/14/93

                                             By:   /s/  Daniel J. Epstein
                                                   ----------------------------
                                             Its:  Trustee
                                                   ----------------------------

                                             Address

                                             1764 San Diego Avenue
                                             San Diego, CA 92110

Shares of Series A-1 Preferred Stock:  20,000
                                       ------------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

         The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                           David J. Epstein

                                           By:   /s/  David J. Epstein
                                                 -------------------------------
                                           Its:  -------------------------------

                                           Address

                                           3 Center Plaza 7/th/ Fl.
                                           Boston, MA 02108

Shares of Series A-1 Preferred Stock:  20,000
                                       ----------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

         The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                            J. Bradley Forrester

                                            By:  /s/  J. Bradley Forrester
                                                 -----------------------------
                                            Its: -----------------------------

                                            Address

                                            P.O. Box 675611
                                            Rancho Santa Fe, CA 92067

Shares of Series A-1 Preferred Stock:  10,000
                                       --------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                       Patrick J. Mahaffy

                                       By:   /s/  Patrick J. Mahaffy
                                             -----------------------------------
                                       Its:  ___________________________________

                                       Address

                                       845 5/th/ St.
                                       Boulder, CO 80302

Shares of Series A-1 Preferred Stock: 10,000
                                      --------------

<PAGE>

                                SIGNATURE PAGE TO

                           INVESTORS' RIGHTS AGREEMENT

                           DATED AS OF MARCH 30, 2001

                           XCEL PHARMACEUTICALS, INC.

     The undersigned hereby executes and delivers the Investors' Rights
Agreement (the "Agreement") to which this Signature Page is attached effective
as of March 30, 2001, which Agreement and Signature Page, together with all
counterparts of such Agreement and Signature Pages of the other parties with
respect to such Agreement, shall constitute one and the same document in
accordance with the terms of such Agreement.

                                Stephens Inc. Custodian fbo John R. Larson, IRA
                                Tax ID # 71-0641478

                                By:   /s/  John R. Larson
                                      -----------------------------------
                                Its:  Owner
                                      -----------------------------------

                                Address

                                111 Center Street
                                Little Rock, AR 72201

Shares of Series A-1 Preferred Stock: 10,000
                                      --------------

<PAGE>

                                   Schedule A
                                   ----------

                              Schedule of Investors
                              ---------------------

Domain Partners V, L.P.

New Enterprise Associates 10, Limited Partnership

NEA Ventures 2001, L.P.

Elan International Services, Ltd.

Cam L. Garner and Wanda D. Garner, Co-Trustees of the
Garner Family Trust dated 10/21/87

Michael T. Borer

James L. Fares

John R. Cook

George Stuart

DP V Associates, L.P.

Todd B. Sisitsky

Charles Ashton Newhall

Ryan Drant

Charles M. Linehan

Hale Family Trust

Mitchell R. Woodbury Trust DTD 7-31-95

Frances M. Spath TTEE Spath Family Trust U/A DTD
05/31/95

David M. Preston Living Trust dated 11/28/00

John B. Kiernan, Jr.

Richard Landgarten

Richard R. Vietor

W. Robert Dahl GST Trust

Evergreen Ventures LLC

R & R Xcel LLC

Thomas D. Erlandson

Jerry E. Canning

Abbott Investment Co., LLC

                                  Schedule A-1
                                  ------------

<PAGE>

James C. Gilstrap IRA

Richard Jaffe

Ronald L. Graham

Alain B. Schreiber, M.D.

Epstein Family Trust, dtd 4/14/93

David J. Epstein

J. Bradley Forrester

Patrick J. Mahaffy

Stephens Inc. Custodian fbo John R. Larson, IRA

                                  Schedule A-1
                                  ------------<PAGE>

                                                                     EXHIBIT 4.4

================================================================================

                           XCEL PHARMACEUTICALS, INC.

                              (formerly MJCB CORP.)

                                 2001 STOCK PLAN

                           (Effective March 30, 2001)

================================================================================

<PAGE>

                           XCEL PHARMACEUTICALS, INC.

                              (formerly MJCB CORP.)

                                 2001 STOCK PLAN

                           (EFFECTIVE March 30, 2001)

                                TABLE OF CONTENTS
                                -----------------

<TABLE>
<S>                                                                    <C>
1.  Purpose .........................................................   1
2.  Definitions .....................................................   1
3.  Administration. .................................................   5
    3.1   Committees of the Board ...................................   5
    3.2   Committee Procedures ......................................   5
    3.3   Authority of the Committee ................................   5
    3.4   Committee Liability .......................................   6
4.  Eligibility .....................................................   6
5.  Stock Subject to Plan. ..........................................   6
    5.1   Basic Limitation ..........................................   6
    5.2   Additional Shares .........................................   6
6.  Terms and Conditions of Grants. .................................   6
    6.1   Form and Amount of Stock Grant ............................   6
    6.2   Stock Grant Agreement .....................................   6
    6.3   Exercisability ............................................   7
    6.4   Vesting ...................................................   7
    6.5   Duration of Stock Grant ...................................   7
    6.6   Purchase Price ............................................   7
    6.7   Effect of Change in Control ...............................   8
    6.8   Rights as Stockholder .....................................   8
7.  Terms and Conditions of Options. ................................   8
    7.1   Stock Option Agreement ....................................   8
    7.2   Number of Shares; Nature of Option ........................   8
    7.3   Purchase Price ............................................   8
    7.4   Exercisability ............................................   9
    7.5   Vesting ...................................................   9
    7.6   Early Exercise ............................................   9
    7.7   Effect of Change in Control ...............................   9
    7.8   Term ......................................................  10
    7.9   Exercise of Options on Termination of Service .............  10
    7.10  No Rights as Stockholder ..................................  10
    7.11  Modification, Extension and Assumption of Options .........  10
8.  Forms of Payment. ...............................................  10
    8.1   General Rule ..............................................  10
    8.2   Surrender of Stock ........................................  10
    8.3   Promissory Notes ..........................................  10
    8.4   Cashless Exercise .........................................  11
</TABLE>

                                      -i-

<PAGE>

<TABLE>
<S>                                                                     <C>
     8.5   Other Forms of Payment ....................................  11
9.   Adjustments upon Changes in Common Stock. .......................  11
     9.1   General ...................................................  11
     9.2   Merger, Consolidation or Other Reorganization .............  11
     9.3   Reservation of Rights .....................................  12
10.  Withholding Taxes. ..............................................  12
     10.1  General ...................................................  12
     10.2  Stock Withholding .........................................  12
     10.3  Cashless Exercise/Pledge ..................................  12
     10.4  Other Forms of Payment ....................................  12
11.  Legal Requirements. .............................................  12
     11.1  Restrictions on Issuance ..................................  12
     11.2  Restrictions on Transfer ..................................  13
     11.3  Financial Reports .........................................  13
12.  Assignment or Transfer of Stock Grant, Option or Shares .........  13
     12.1  General ...................................................  13
     12.2  Trusts ....................................................  13
     12.3  Company's Right to Repurchase Shares ......................  13
13.  No Employment Rights ............................................  14
14.  Duration and Amendments. ........................................  14
     14.1  Term of the Plan ..........................................  14
     14.2  Right to Amend or Terminate the Plan ......................  14
     14.3  Effect of Amendment or Termination ........................  14
15.  Execution .......................................................  14
</TABLE>

                                      -ii-

<PAGE>

                           XCEL PHARMACEUTICALS, INC.

                              (formerly MJBC CORP.)

                                 2001 STOCK PLAN

1.      Purpose. The purpose of the Plan is to offer selected employees,
directors and consultants an opportunity to acquire a proprietary interest in
the success of the Company, or to increase such interest, to encourage such
persons to remain in the employ of the Company and to attract new employees with
outstanding qualifications. The Plan seeks to achieve this purpose by providing
for the direct grant or sale of Shares of the Company's Stock and for the grant
of Options to purchase Shares of the Company's Stock. Options granted under the
Plan may include Nonstatutory Stock Options as well as Incentive Stock Options
intended to qualify under Section 422 of the Code. While this Plan is intended
to satisfy Rule 701 under the Securities Act and Section 25102(o) of the
Corporations Code, Options may be granted and Shares may be awarded or sold
under this Plan in reliance upon other federal and state securities law
exemptions and to the extent another exemption is relied upon, the terms of this
Plan which are required only because of Rule 701 or Section 25102(o) need not
apply to the extent provided by the Board in the Stock Option Agreement or the
Stock Grant Agreement, as the case may be.

2.      Definitions.  The following terms shall have the meanings set forth in
this Section 2.

        "Board" shall mean the Board of Directors of the Company, as constituted
from time to time.

        "Cause" means (i) the Key Contributor's conviction of any felony; (ii)
the Key Contributor's commission of any act of fraud or embezzlement; or (iii)
any willful failure of the Key Contributor to perform his duties or
responsibilities, which either (x) in the case of any ongoing violation, the Key
Contributor does not cease within a reasonable period after receiving written
notice of the alleged deficiencies or (y) in the case of a violation capable of
being cured, the Key Contributor does not cure within thirty (30) days after
receiving written notice of the alleged deficiencies.

        "Change in Control" shall mean:

        (i)     The consummation of a merger or consolidation of the Company
with or into another entity or any other corporate reorganization, if more than
50% of the combined voting power of the continuing or surviving entity's
securities outstanding immediately after such merger, consolidation or other
reorganization is owned by persons who were not stockholders of the Company
immediately prior to such merger, consolidation or other reorganization; or

        (ii)    Any transaction (other than an issuance of shares by the Company
for cash) in or by means of which one or more persons acting in concert acquire,
in the aggregate, more than 50% of the combined voting power of Company's
outstanding equity securities; or

        (iii)   The sale, transfer or other disposition of all or substantially
all of the Company's assets; or

                                      -1-

<PAGE>

        (iv)    Any other event determined by the Board to constitute a Change
in Control for purposes of the Plan.

A transaction shall not constitute a Change in Control if: (a) its sole purpose
is to change the state of the Company's incorporation; (b) its sole purpose is
to create a holding company that will be owned in substantially the same
proportions by the persons who held the Company's securities immediately before
such transaction; or (c) it constitutes the Company's initial public offering of
its securities.

        "Code" shall mean the Internal Revenue Code of 1986, as amended.

        "Committee" shall mean a committee consisting of one or more members of
the Board that is appointed by the Board to administer the Plan under Section 3.

        "Common-Law Employee" shall mean an individual paid from W-2 Payroll of
the Company or a Subsidiary. If, during any period, the Company (or a
Subsidiary, as applicable) has not treated an individual as a Common-Law
Employee and, for that reason, has not paid such individual in a manner which
results in the issuance of a Form W-2 and withheld taxes with respect to him or
her, then that individual shall not be an eligible Common-Law Employee for that
period, even if any person, court or government agency determines,
retroactively, that such individual is or was a Common-Law Employee during all
or any portion of that period.

        "Company" shall mean Xcel Pharmaceuticals, Inc. (formerly, MJBC Corp.),
a Delaware corporation.

        "Consultant" shall mean an individual who performs bona fide Service
                                                           ---------
other than as a Common-Law Employee, a member of the Board, or a member of the
board of directors of a Subsidiary.

        "Corporations Code" shall mean the California Corporations Code.

        "Exchange Act" shall mean the Securities and Exchange Act of 1934, as
amended.

        "Fair Market Value" shall mean the determination of the market price of
Shares of the Company's Stock made by the Board, which in all cases shall be
conclusive and binding on all persons in accordance with the following
guidelines:

        (i)     If the Shares are traded over-the-counter on the Valuation Date
but are not traded on the Nasdaq Stock Market or the Nasdaq National Market
System, the Fair Market Value shall be equal to the mean between the last
reported representative bid and asked prices quoted for the Valuation Date by
the principal automated inter-dealer quotation system on which the Shares are
quoted or, if the Shares are not quoted on any such system, by the "Pink Sheets"
published by the National Quotation Bureau, Inc.;

        (ii)    If the Shares are traded over-the-counter on the Valuation Date
and are traded on the Nasdaq Stock Market or the Nasdaq National Market System,
the Fair Market Value shall be equal to the last-transaction price quoted for
the Valuation Date by the Nasdaq Stock Market or the Nasdaq National Market;

                                      -2-

<PAGE>

        (iii)   If the Shares are traded on a stock exchange on the Valuation
Date, the Fair Market Value shall be equal to the closing price reported by the
applicable composite transactions report for the Valuation Date; and

        (iv)    If none of the foregoing provisions is applicable, the Fair
Market Value shall be determined by the Board in good faith on such basis as it
deems appropriate.

        "Good Reason" means (i) a material reduction in the Key Contributor's
level of duties or responsibilities or the nature of the Key Contributor's
functions; (ii) a reduction in the Key Contributor's base salary or a reduction
in the Key Contributor's total cash compensation (consisting of base salary and
target bonus); (iii) a relocation of the Key Contributor's principal place of
employment by more than thirty (30) miles, if the new location is both (A) more
than thirty (30) miles from the Key Contributor's principle residence and (B)
farther from the Key Contributor's principal residence than the Key
Contributor's principal place of employment immediately before such relocation;
or (iv) the repudiation or failure by the Company or its successor to
acknowledge (upon the Key Contributor's written request) or to comply with any
of its obligations under any employment agreement with the Key Contributor. The
Company shall have the right, within thirty (30) days after receiving written
notice from the Key Contributor, to cease any ongoing violation or cure any
violation capable of being cured which would give rise to a termination for Good
Reason.

        "Grantee" shall mean the holder of a Stock Grant.

        "Incentive Stock Option" shall mean an incentive stock option described
in Section 422(b) of the Code.

        "Involuntary Termination" shall mean the termination of an Optionee's
or Grantee's Service by reason of:

        (i)     The involuntary discharge of the Optionee or Grantee by the
Company (or the Parent or Subsidiary employing him or her) or any successor to
the Company after a Change in Control for reasons other than Cause; or

        (ii)    The voluntary resignation of the Optionee or Grantee for Good
Reason.

        "Key Contributor" shall mean: (i) an individual who is a Common-Law
Employee of the Company, a Parent or a Subsidiary; (ii) a member of the Board,
including (without limitation) a Non-Employee Director, or an affiliate of a
member of the Board; (iii) a member of the board of directors of a Subsidiary;
or (iv) a Consultant.

        "Non-Employee Director" shall mean a member of the Board who is not a
Common-Law Employee of the Company or a Subsidiary and who is otherwise not
disqualified from being a "non-employee director," as set forth in Rule 16b-3
promulgated under the Exchange Act.

        "Nonstatutory Stock Option" shall mean a stock option that is not an
Incentive Stock Option.

                                      -3-

<PAGE>

        "Option" shall mean an Incentive Stock Option or Nonstatutory Stock
Option granted under the Plan entitling the holder to purchase Shares.

        "Optionee" shall mean holder of an Option.

        "Parent" shall have the meaning set forth in Section 424(e) of the
Code.

        "Participant" shall mean an individual or estate that holds an Option
or Stock Grant.

        "Plan" shall mean this 2001 Stock Plan of Xcel Pharmaceuticals, Inc.
(formerly, MJBC Corp.),

        "Purchase Price" shall mean the consideration for which one Share may
be acquired under the Plan.

        "Securities Act" shall mean the Securities Act of 1933, as amended.

        "Share" shall mean one share of Stock, as adjusted in accordance with
Section 9 of the Plan.

        "Service" shall mean service as a Key Contributor.

        "Stock" shall mean the Company's common stock.

        "Stock Acquisition Agreement" shall mean the agreement between the
Company and a person who acquires Shares under the Plan whether pursuant to an
Option or a Stock Grant.

        "Stock Grant" shall mean a right to acquire Shares under the Plan other
than by the exercise of an Option.

        "Stock Grant Agreement" shall mean the agreement between the Company and
a Grantee that contains the terms, conditions and restrictions pertaining to a
Stock Grant.

        "Stock Option Agreement" shall mean the agreement between the Company
and an Optionee that contains the terms, conditions and restrictions pertaining
to an Option.

        "Subsidiary" shall have the meaning set forth in Section 424(f) of the
Code.

        "Ten Percent Stockholder" shall mean an individual who owns more than
10% of the total combined voting power of all classes of outstanding stock of
the Company, its Parent or any of its Subsidiaries. In determining stock
ownership, the attribution rules of Section 424(d) of the Code shall be applied
and "outstanding stock" shall include all stock actually issued and outstanding
immediately after granting of an Option or Stock Grant, but shall not include
Shares authorized for issuance under outstanding Options held by a Key
Contributor or by any other person.

                                      -4-

<PAGE>

        "Total and Permanent Disability" shall mean a Key Contributor's
inability to engage in any substantial gainful activity by reason of any
medically determinable physical or mental impairment.

        "Valuation Date" shall mean the date on which the Fair Market Value of
Shares is determined.

        "W-2 Payroll" shall mean the mechanism or procedure the Company or a
Subsidiary utilizes to pay any individual which results in the issuance of
Internal Revenue Service Form W-2 to the individual. "W-2 Payroll" does not
include any mechanism or procedure which results in the issuance of any Internal
Revenue Service form other than Form W-2 to an individual, including, but not
limited to, Form 1099. Whether a mechanism or procedure constitutes "W-2
Payroll" shall be determined in the absolute discretion of the Company (or
Subsidiary, as applicable), and such determination shall be conclusive and
binding on all persons.

3.      Administration.

        3.1     Committees of the Board. The Plan shall be administered by the
Board (which, in the absence of a specific designation of a committee, shall be
the Committee); however, any or all administrative functions otherwise
exercisable by the Board may be delegated to a Committee. Members of the
Committee shall serve for such period of time as the Board may determine and
shall be subject to removal by the Board at any time. The Board may also at any
time terminate the functions of the Committee and reassume all powers and
authority previously delegated to the Committee. If a Committee has been
appointed, any reference to the Board in the Plan shall be construed as a
reference to the Committee to whom the Board has assigned a particular function.
If the Company's Stock becomes publicly traded, the Board may appoint a
Committee which, if appointed, shall be comprised solely of two or more
Non-Employee Directors (although Committee functions may be delegated to
officers to the extent the Options or Stock Grants are made to persons who are
not subject to the reporting requirements of Section 16 of the Exchange Act).

        3.2     Committee Procedures. The Board shall designate one of the
members of the Committee as chairperson. The Committee may hold meetings at such
times and places as it shall determine. The acts of a majority of the Committee
members present at meetings at which a quorum exists, or acts reduced to or
approved in writing by all Committee members, shall be valid acts of the
Committee.

        3.3     Authority of the Committee. Subject to the provisions of the
Plan, the Committee shall have full authority and discretion to take any actions
it deems necessary or advisable for the administration of the Plan. The
Committee has authority to determine, in its sole discretion, to whom, and the
time or times at which, Options or Stock Grants may be made and the number of
Shares subject to each Option or Stock Grant. The Committee has authority to
prescribe, amend and rescind rules and regulations relating to the Plan and to
make all other determinations necessary or advisable for Plan administration.
All decisions, interpretations and other actions of the Committee shall be
final, conclusive and binding on all parties who have an interest in the Plan or
any Option or Shares issued thereunder.

                                      -5-

<PAGE>

        3.4     Committee Liability.  No member of the Board or the Committee
will be liable for any action or determination made in good faith by the
Committee with respect to the Plan or any Award made under the Plan.

4.      Eligibility.  Only Key Contributors shall be eligible for designation as
Participants by the Board. In addition, only individuals who are Common-Law
Employees shall be eligible for the grant of Incentive Stock Options.

5.      Stock Subject to Plan.

        5.1     Basic Limitation. The Shares issuable under the Plan shall be
authorized but unissued or reacquired Shares of Stock. The maximum number of
Shares which may be issued under the Plan shall not exceed 1,480,000 Shares,
subject to adjustment pursuant to Section 10. In any event, (i) the number of
Shares subject to Options or Stock Grants outstanding at any time under the Plan
shall not exceed the number of Shares which then remain available for issuance
under the Plan; and (ii) to the extent an award is made in reliance upon the
exemption available under Section 25102(o) of the Corporations Code, the number
of Shares subject to Options or Stock Grants outstanding at any time under the
Plan (together with other shares of Stock that must be aggregated for this
purpose) shall not exceed the limitation imposed by Section 260.140.45 of Title
10 of the California Code of Regulations or Section 25102(o) of the Corporations
Code. The Company, during the term of the Plan, shall at all times reserve and
keep available sufficient Shares to satisfy the requirements of the Plan. The
number of Shares that may be issued or transferred to any Key Contributor during
any twelve (12) month period pursuant to any Options or Stock Grants (in the
aggregate) shall not exceed 200,000 Shares.

        5.2     Additional Shares. If any outstanding Option or Stock Grant
expires or is canceled, forfeited or otherwise terminated, the Shares allocable
to the unexercised portion of such Option or Stock Grant shall again be
available for issuance under the Plan. If Shares issued under the Plan are
reacquired by the Company pursuant to any right of repurchase or right of first
refusal, such Shares shall again be available for issuance under the Plan,
except that the aggregate number of Shares that may be issued upon the exercise
of Incentive Stock Options shall in no event exceed the number of Shares
reserved for issuance pursuant to Section 5.1 plus the number of Shares that
revert to the Plan pursuant to the first sentence of this Section 5.2, as
adjusted pursuant to Section 9.

6.      Terms and Conditions of Grants.

        6.1     Form and Amount of Stock Grant. Each Stock Grant shall specify
the number of Shares that are subject to the Stock Grant. A Stock Grant may be
awarded in combination with a Nonstatutory Stock Option and such a Stock Grant
may provide that the Shares subject to the Stock Grant will be forfeited in the
event that the related Nonstatutory Stock Option is exercised.

        6.2     Stock Grant Agreement. Each Stock Grant shall be evidenced by a
Stock Grant Agreement between the Grantee and the Company. Each Stock Grant
shall be subject to all applicable terms and conditions of the Plan and may be
subject to any other terms and conditions that are not inconsistent with the
Plan as the Board deems appropriate for inclusion in a Stock

                                      -6-

<PAGE>

Acquisition Agreement. The provisions of the various Stock Grant Agreements
entered into under the Plan need not be identical.

        6.3     Exercisability. Each Stock Acquisition Agreement shall specify
the conditions upon which the Stock Grant shall become exercisable, if
applicable, which shall be determined by the Board in its sole discretion. If
required by applicable law, however, including the Corporations Code or the
regulations thereunder, each Stock Grant shall become exercisable no less
rapidly than the rate of 20% per year for each of the first five (5) years from
the date of the Stock Grant.

        6.4     Vesting.

                6.4.1   General. Each Stock Grant shall specify the conditions
                        -------
upon which the Grantee's rights in the Shares subject to the Stock Grant shall
vest, which shall be determined by the Board in its sole discretion. If required
by applicable law, however, including the Corporations Code or the regulations
thereunder, the Shares subject to each Stock Grant shall vest no less rapidly
than the rate of 20% per year for each of the first five (5) years from the date
of the Stock Grant.

                6.4.2   Accelerated Vesting. Unless the applicable Stock
                        -------------------
Acquisition Agreement provides otherwise, any right to repurchase a Grantee's
Shares at the original Purchase Price (if any) upon termination of the Grantee's
Service shall lapse and all of such Shares shall become vested if the following
occur:

                        (i)     The Company is subject to a Change in Control
before the Grantee's Service terminates; and

                        (ii)    Either of the following occurs:

                                (A)     The repurchase right is not assigned to

or held by the entity that employs the Grantee immediately after the Change in
Control or to its Parent or Subsidiary; or

                                (B)     The Grantee is subject to an Involuntary
Termination within eighteen (18) months following such Change in Control.

        6.5     Duration of Stock Grant. Any Stock Grant shall automatically
expire thirty (30) days after the Stock Grant is communicated in writing to the
Grantee if the Grantee does not, within such thirty (30) day period, accept the
Stock Grant by signing the Stock Grant Agreement.

        6.6     Purchase Price. The Purchase Price of Shares offered under a
Stock Grant shall be established by the Board and set forth in the Stock Grant
Agreement. To the extent required by applicable law, including the Corporations
Code or the regulations thereunder, the Purchase Price shall not be less than
85% of Fair Market Value (100% for Ten Percent Stockholders). In no event will
the Purchase Price be less than the par value of a Share. The Purchase Price
shall be payable in a form described in Section 8 or, in the discretion of the
Board, in consideration for past services rendered to the Company or for its
benefit.

                                      -7-

<PAGE>

     6.7  Effect of Change in Control. The Board may determine at the time of
making a Stock Grant or thereafter, that upon a Change in Control such Stock
Grant shall become exercisable as to all or a portion of the Shares subject to
the Stock Grant or that the vesting of a Grantee's rights in all or a portion of
the Shares subject to such Stock Grant shall be accelerated.

     6.8  Rights as Stockholder. Holders of Shares acquired under the Plan shall
have the same voting, dividend and other rights as the Company's other
stockholders. A Stock Grant, however, may require that the holder of Shares
acquired under such Stock Grant invest any cash dividends received in additional
Shares. Such additional Shares shall be subject to the same conditions and
restrictions as the Shares with respect to which the dividends were paid. Such
additional Shares shall not reduce the number of Shares available for issuance
under the Plan.

7.   Terms and Conditions of Options.

     7.1  Stock Option Agreement. Each grant of an Option under the Plan shall
be evidenced by a Stock Option Agreement between the Optionee and the Company.
Such Option shall be subject to all applicable terms and conditions of the Plan
and may be subject to any other terms and conditions that are not inconsistent
with the Plan and that the Board deems appropriate for inclusion in a Stock
Option Agreement. The provisions of the various Stock Option Agreements entered
into under the Plan need not be identical.

     7.2  Number of Shares; Nature of Option. Each Stock Option Agreement shall
specify the number of Shares that are subject to the Option and shall provide
for the adjustment of such number of Shares in accordance with Section 9. The
Stock Option Agreement shall also specify whether the Option is an Incentive
Stock Option or a Nonstatutory Stock Option. Notwithstanding such designation,
however, to the extent the aggregate Fair Market Value of the Shares with
respect to which Incentive Stock Options are exercisable for the first time by
the Optionee during any calendar year (under all plans of the Company and any
Parent or Subsidiary) exceeds $100,000, such Options shall be treated as
Nonstatutory Stock Options. For purposes of this Section 7.2, Incentive Stock
Options shall be taken into account in the order in which they were granted. The
Fair Market Value of the Shares shall be determined as of the time the Option
with respect to such Shares is granted.

     7.3  Purchase Price. The Purchase Price of Shares subject to an Option
shall be established by the Board and set forth in a Stock Option Agreement. The
Purchase Price of Shares subject to an Incentive Stock Option shall not be less
than 100% of the Fair Market Value (110% for Ten Percent Stockholders) on the
date the Option is granted. If required by applicable law, including the
Corporations Code or the regulations thereunder, the Purchase Price of Shares
subject to a Nonstatutory Stock Option shall not be less than 85% of the Fair
Market Value (110% for Ten Percent Stockholders) on the date the Option is
granted. In no event shall the Purchase Price be less than the par value of a
Share. The Purchase Price shall be payable in a form described in Section 8.
Notwithstanding the foregoing, an Option may be granted with a Purchase Price
lower than that prescribed in this Section 7.3 if the Option grant is
attributable to the issuance or assumption of an option in a transaction to
which Section 424(a) of the Code applies.

                                      -8-

<PAGE>

     7.4  Exercisability. Each Stock Option Agreement shall specify the date
when the Option becomes exercisable, which shall be determined by the Board in
its sole discretion. If required by applicable law, however, including the
Corporations Code or the regulations thereunder, Options granted to Key
Contributors who are not officers shall become exercisable no less rapidly than
the rate of 20% per year for each of the first five (5) years from the date the
Option is granted.

     7.5  Vesting.

          7.5.1  General. Each Stock Option Agreement shall specify the date or
                 -------
events upon which the Optionee's rights in the Shares subject to the Option
shall vest, which shall be determined by the Board in its sole discretion. If
required by applicable law, however, including the Corporations Code or the
regulations thereunder, Shares subject to Options granted to Key Contributors
who are not officers shall vest no less rapidly than the rate of 20% per year
for each of the first five (5) years from the date the Option is granted.

          7.5.2  Accelerated Vesting. Unless the applicable Stock Option
                 -------------------
Agreement provides otherwise, any right to repurchase an Optionee's shares at
the original Purchase Price upon termination of the Optionee's Service shall
lapse and all of such Shares shall become vested if the following occur:

                 (i)   The Company is subject to a Change in Control before the
Optionee's Service terminates; and

                 (ii)  Either of the following occurs:

                       (A)  Such Options do not remain outstanding, such Options
are not assumed by the surviving corporation and the surviving corporation does
not substitute new options with substantially the same terms for such Options;
or

                       (B)  The Optionee is subject to an Involuntary
Termination within eighteen (18) months following such Change in Control.

     7.6  Early Exercise. A Stock Option Agreement may permit an Optionee to
exercise an Option before it is vested (i.e., make an "early exercise"), subject
                                        ----
to the Company's right to repurchase Shares acquired under the Option. The
Company's right to repurchase Shares shall lapse at the same rate as the
Optionee's rights in the Shares would have vested in accordance with Section 7.5
had there been no early exercise. If required by applicable law, including the
Corporations Code or the regulations thereunder, the Company's right to
repurchase Shares may be exercised only within ninety (90) days after the later
of (i) the termination of the Optionee's Service or (ii) the date of exercise of
the Option, and in any event for cash or for cancellation of indebtedness
incurred in purchasing the Shares.

     7.7  Effect of Change in Control. The Board may determine, at the time of
granting an Option or thereafter, that upon a Change in Control such Option
shall become exercisable as to all or a portion of the Shares subject to the
Option or that the vesting of an Optionee's rights in all or a portion of the
Shares subject to such Option shall be accelerated.

                                      -9-

<PAGE>

     7.8   Term. The Stock Option Agreement shall specify the term of the
Option. The term shall not exceed ten (10) years from the date of grant or, in
the case of an Incentive Stock Option granted to a Ten Percent Stockholder, five
(5) years from the date of grant. Subject to the preceding sentence, the Board
in its sole discretion, shall determine when an Option will expire.

     7.9   Exercise of Options on Termination of Service. Each Option shall set
forth the extent to which the Optionee shall have the right to exercise the
Option following termination of the Optionee's Service with the Company and its
Subsidiaries. Such provisions shall be determined in the sole discretion of the
Board, need not be uniform among all Optionees, and may reflect distinctions
based on the reasons for termination of Service. If required by applicable law,
however, including the Corporations Code or the regulations thereunder, each
Stock Option Agreement shall provide the Optionee with the right to exercise the
Option following the Optionee's termination of Service during the Option term
(x) for at least thirty (30) days if termination of Service is due to any reason
other than Cause, death or Total and Permanent Disability, and (y) for at least
six (6) months after termination of Service if due to death or Total and
Permanent Disability.

     7.10  No Rights as Stockholder. An Optionee, or a transferee of an
Optionee, shall have no rights as a stockholder with respect to any Shares
subject to an Option until such person becomes entitled to receive such Shares
by delivering to the Company a signed Stock Acquisition Agreement and paying the
Purchase Price pursuant to the terms of such Option.

     7.11  Modification, Extension and Assumption of Options. Within the
limitations of the Plan, the Board may modify, extend or assume outstanding
Options or may accept the cancellation of outstanding Options (whether granted
by the Company or another issuer) in return for the grant of new Options for the
same or a different number of Shares and at the same or a different Purchase
Price. The foregoing notwithstanding and except as set forth in Section 9.2, no
modification of an Option shall, without the consent of the Optionee, impair the
Optionee's rights or increase the Optionee's obligations under such Option.

8.   Forms of Payment.

     8.1   General Rule. Except as otherwise provided in this Section 8, the
entire Purchase Price shall be payable in cash or cash equivalents acceptable to
the Company at the time of purchase.

     8.2   Surrender of Stock. To the extent that a Stock Option Agreement or
Stock Grant Agreement so provides, payment may be made wholly or in part with
Stock that has already been owned by the Optionee or Grantee, or the
representative of either, for such time period as may be specified by the Board
and that is surrendered to the Company in good form for transfer. Such Stock
shall be valued at Fair Market Value on the date when the new Shares are
acquired under the Plan.

     8.3   Promissory Notes. To the extent that a Stock Option Agreement or
Stock Grant Agreement so provides, payment may be made wholly or in part with a
full recourse promissory note executed by the Optionee or Grantee. The interest
rate and other terms and conditions of such note shall be determined by the
Board. The Board may require that the Optionee or Grantee

                                      -10-

<PAGE>

pledge Shares to the Company for the purpose of securing payment of such note.
In no event shall the stock certificate(s) representing such Shares be released
to the Optionee or Grantee until such note is paid in full, unless otherwise
provided in the Stock Option Agreement, Stock Grant Agreement or Stock
Acquisition Agreement.

     8.4  Cashless Exercise. To the extent provided in a Stock Option Agreement
or Stock Grant Agreement, if a public market for the Stock exists, payment may
be made by delivery (on a form acceptable to the Board) of an irrevocable
direction to a securities broker to sell Stock and to deliver all or part of the
sale proceeds to the Company in payment of the aggregate Purchase Price.

     8.5  Other Forms of Payment. To the extent provided in a Stock Option
Agreement or Stock Grant Agreement, payment may be made in any other form that
is consistent with applicable laws, regulations and rules.

9.   Adjustments upon Changes in Common Stock.

     9.1  General. In the event of a subdivision of the outstanding Stock, a
declaration of a dividend payable in Stock, a combination or consolidation of
the outstanding Stock into a lesser number of shares, a recapitalization, a
reclassification of the outstanding Stock or such other event as the Board may
determine necessitates an adjustment be made, the Board shall make appropriate
adjustments, subject to the limitations set forth in Section 9.3, in one or more
of (i) the number of Shares of Stock available for future grants of Options or
Stock Grants, (ii) the number of Shares of Stock covered by each outstanding
Option or Stock Grant or (iii) the Purchase Price of each outstanding Option or
Stock Grant.

     9.2  Merger, Consolidation or Other Reorganization. If the Company is a
party to a merger, consolidation or other corporate reorganization, outstanding
unexercised Options shall be subject to the terms and conditions of the
agreement between the Company and the other party to such merger, consolidation
or reorganization and such Options may be assumed, substituted, modified or
cancelled, without the consent of any Optionee, as the Board, in its sole
discretion, may determine. By way of example only, and not in limitation of the
Board's authority, any such agreement may provide for any of the following:

               (i)   The continuation of such outstanding Options by the Company
(if the Company is the surviving corporation); or

               (ii)  The assumption of the Plan and such outstanding Options by
the surviving corporation or its parent; or

               (iii) The substitution by the surviving corporation or its parent
of options with substantially the same terms for such outstanding Options; or

               (iv)  The cancellation of each outstanding Option (whether vested
or unvested) after payment to the Optionee of an amount in cash or cash
equivalents equal to (A) the Fair Market Value at the time of the merger,
consolidation or other reorganization of the Shares subject to such Option (to
the extent then vested) minus (B) the Purchase Price of the Shares subject to
such Option.

                                      -11-

<PAGE>

     9.3   Reservation of Rights. Except as set forth in Section 9.1, an
Optionee or Grantee shall have no rights by reason of (i) any subdivision or
consolidation of shares of Company stock of any class, (ii) the payment of any
dividend by the Company, or (iii) any other increase or decrease in the number
of shares of Company stock of any class. Except as set forth in Section 9.1, any
issuance by the Company of shares of stock of any class, or securities
convertible into shares of stock of any class, shall not affect, and no
adjustment by reason thereof shall be made with respect to, the number of Shares
subject to an Option, the number of Shares subject to any Stock Grant and/or the
Purchase Price under any Option or Stock Grant. The grant of an Option or a
Stock Grant pursuant to the Plan shall not affect in any way the right or power
of the Company to make adjustments, reclassifications, reorganizations or
changes of its capital or business structure, to merge, consolidate or
reorganize or to dissolve or liquidate or sell, transfer or otherwise dispose of
all or any part of its business, assets or securities.

10.  Withholding Taxes.

     10.1  General. To the extent required by applicable federal, state, local
or foreign law, a Participant shall make arrangements satisfactory to the
Committee for the satisfaction of any withholding tax obligations that arise in
connection with the Plan. The Company shall not be required to issue any Shares
or make any cash payment under the Plan until such obligations are satisfied.

     10.2  Stock Withholding. The Committee may permit a Participant to satisfy
all or part of the withholding or income tax obligations by having the Company
withhold all or a portion of any Shares of Stock that otherwise would be issued
or by surrendering all or a portion of any Shares of Stock previously acquired.
Shares of Stock that are withheld or surrendered pursuant to this Section 10
shall be valued at their Fair Market Value on the date when taxes otherwise
would be withheld in cash. Any payment of taxes by assigning Shares of Stock to
the Company may be subject to restrictions, including any restrictions required
by rules of any federal or state regulatory body or other authority.

     10.3  Cashless Exercise/Pledge. The Committee may provide that if Company
Shares of Stock are publicly traded at the time of exercise, arrangements may be
made to meet the Optionee's withholding obligation by cashless exercise or
pledge.

     10.4  Other Forms of Payment. The Committee may permit such other means of
tax withholding as it determines to be appropriate.

11.  Legal Requirements.

     11.1  Restrictions on Issuance. Shares shall not be issued under the Plan
unless the issuance and delivery of such Shares complies with (or is exempt
from) all applicable requirements of law, including (without limitation) the
Securities Act, the rules and regulations promulgated thereunder, state
securities laws and regulations, and the regulations of any stock exchange on
which the Company's securities may then be listed, and the Company has obtained
the approval of or a favorable ruling from any governmental agency that the
Company determines to be necessary or advisable.

                                      -12-

<PAGE>

     11.2  Restrictions on Transfer. If the Company or any managing underwriter
of an offering of securities of the Company so determines, no Shares issued upon
exercise of a Stock Grant or an Option may be sold or otherwise transferred or
disposed of during a period of up to one hundred eighty (180) days following the
effective date of a registration statement covering securities of the Company
filed under the Securities Act. Any Shares issued upon exercise of a Stock Grant
or an Option shall be subject to such rights of repurchase, rights of first
refusal and other transfer restrictions as the Board may determine. Such
restrictions shall apply in addition to any restrictions that may apply to
holders of Stock generally.

     11.3  Financial Reports. To the extent required to comply with the
Corporations Code or the regulations thereunder, not less often than annually
the Company shall furnish to Optionees and Grantees summary financial
information, including a balance sheet, regarding the Company's financial
condition and results of operations, unless such Optionees or Grantees have
duties with the Company that assure them access to equivalent information. Such
financial statements need not be audited.

12.  Assignment or Transfer of Stock Grant, Option or Shares.

     12.1  General. No Stock Grant or Option shall be anticipated, assigned,
attached, garnished, optioned, transferred or made subject to any creditor's
process, whether voluntarily, involuntarily or by operation of law, except as
approved by the Committee. Notwithstanding the foregoing:

               (i)   while the Shares are subject to Corporations Code Section
25102(o), (a) Grantees and Optionees may not transfer their rights hereunder
except by will, beneficiary designation or the laws of descent and distribution,
and (b) any rights of repurchase in favor of the Company shall take into account
the provisions of Sections 260.140.41 or 260.140.42 of Title 10 of the
California Code of Regulations, as applicable; and

               (ii)  Incentive Stock Options may not be transferred or alienated
in any way.

     12.2  Trusts. Neither this Section 12 nor any other provision of the Plan
shall preclude a Participant from transferring or assigning Shares to (i) the
trustee of a trust that is revocable by such Participant alone, both at the time
of the transfer or assignment and at all times thereafter prior to such
Participant's death, or (ii) the trustee of any other trust to the extent
approved by the Committee in writing. A transfer or assignment of Shares from
such trustee to any person other than such Participant shall be permitted only
to the extent approved in advance by the Committee in writing, and Shares held
by such trustee shall be subject to all the conditions and restrictions set
forth in the Plan and in the applicable Stock Acquisition Agreement, as if such
trustee were a party to such Stock Acquisition Agreement.

     12.3  Company's Right to Repurchase Shares. The Company shall have the
right to repurchase a Participant's Shares that have been acquired through a
Stock Grant or an Option upon termination of the Participant's Service if
provided in the applicable Stock Acquisition Agreement. If the Company retains a
right to repurchase Shares at their Fair Market Value on the date that the
Participant's Service terminates, then such repurchase right shall terminate
when

                                      -13-

<PAGE>

the Company's Stock becomes publicly traded. If the Company retains a right to
repurchase Shares at the original Purchase Price, then such repurchase right
shall lapse at the minimum rate of twenty percent (20%) per year over the five
(5) year period starting on the date that the Stock Grant or Option was granted.
The foregoing restrictions on the Company's right of repurchase shall not apply
to Options and Stock Grants granted to Non-Employee Directors, Consultants or
officers of the Company, a Parent or a Subsidiary and repurchase rights
applicable to Shares held by such persons may be subject to additional greater
restrictions, as determined by the Board.

13.  No Employment Rights. No provision of the Plan, nor any Option or Stock
Grant shall be construed to give any person any right to become, to be treated
as, or to remain a Key Contributor. The Company and its Subsidiaries reserve the
right to terminate any Key Contributor's employment at any time and for any
reason or for no reason, with or without Cause.

14.  Duration and Amendments.

     14.1  Term of the Plan. The Plan, as set forth herein, shall become
effective on the date of its adoption by the Board, subject to the approval of
the Company's stockholders. If the stockholders fail to approve the Plan within
twelve (12) months after its adoption by the Board, any Options or Stock Grants
granted within such twelve (12) month period shall be null and void, and no
additional Options or Stock Grants shall be granted after the expiration of such
twelve (12) month period. The Plan shall terminate automatically ten (10) years
after its adoption by the Board and may be terminated on any earlier date
pursuant to Section 14.2 below.

     14.2  Right to Amend or Terminate the Plan. The Board may amend or
terminate the Plan at any time. Except as may otherwise be permitted under
Section 9.2, rights under any Option or Stock Grant granted before amendment or
termination of the Plan shall not be materially impaired by any such amendment
or termination, except with consent of the Optionee or Grantee. An amendment of
the Plan shall be subject to the approval of the Company's stockholders only to
the extent required by applicable laws, regulations or rules.

     14.3  Effect of Amendment or Termination. No Shares shall be issued or sold
under the Plan after the termination thereof, except upon exercise of an Option
or Stock Grant granted prior to such termination. Except as may be permitted
under Section 9.2, the termination of the Plan, or any amendment thereof, shall
not affect any Shares previously issued or Option or Stock Grant previously
granted under the Plan.

15.  Execution. To record the adoption of the Plan, the Company has caused its
authorized officer to execute the same.

                                         Xcel Pharmaceuticals, Inc.
                                         (formerly, MJBC Corp.),

                                         By:   /s/ Michael T. Borer
                                               --------------------------

                                         Its:  President & CEO
                                               --------------------------

                                      -14-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00033-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00033-of-00352.parquet"}]]